| Citation: |
WENG Zhihua, WANG Lei, ZHOU Jun. Value of Leu(CAG)-tRNA fragments in diagnosis and prognosis of lung adenocarcinoma and its relationship with clinical features[J]. Journal of Clinical Medicine in Practice, 2022, 26(15): 19-25. DOI: 10.7619/jcmp.20221478
|
To investigate the value of Leu (CAG)-tRNA fragment(tRF-LeuCAG) in evaluation of diagnostic efficacy, survival prognosis of lung adenocarcinoma (LAC) and its relationship with clinical features.
The clinicopathological data of 68 pairs of surgically resected LAC tissues and normal adjacent lung tissues were collected. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the relative expression of tRF-LeuCAG RNA in LAC and adjacent normal tissues (NC); the relationship between the expression level of tRF-LeuCAG and clinicopathological features was analyzed. The positive expression of tRF-LeuCAG was detected by RNA in situ molecular hybridization (RISH). Receiver operating characteristic (ROC) curve was used to analyze the diagnostic efficacy of tRF-LeuCAG for LAC. Kaplan-meier method was used to analyze the 3-year survival curve of LAC patients. Transwell experiment was used to detect the effect of tRF-LeuCAG on the migration of lung cancer cells.
The expression level of tRF-LeuCAG in the LAC tissues was significantly higher than that in the adjacent normal lung tissues (P < 0.05); the expression level of tRF-LeuCAG in patients with the lymph node metastasis was significantly higher than that in patients without the lymph node metastasis (P < 0.05). The expression level of tRF-LeuCAG was significantly correlated with the degree of differentiation of LAC and lymph node metastasis (P < 0.05), but had no correlation with age, gender, smoking, tumor diameter, tumor grade and TNM stage (P > 0.05). The positive rate of tRF-LeuCAG in the LAC tissues was 73.53% (50/68), which was significantly higher than 13.24% (9/68) in the normal adjacent lung tissues (P < 0.05). The ROC curve showed that the diagnostic efficacy indexes of tRF-LeuCAG and carcinoembryonic antigen (CEA) in LAC were as follows. The area under the curve (AUC) was 0.869 and 0.852, 95%CI was 0.806 to 0.926 and 0.794 to 0.910, sensitivity was 86.2% and 83.6%, specificity was 80.5% and 85.8%, Youden inde was 0.643 and 0.608, respectively. Of the 68 LAC patients, 53 had high tRF-LeuCAG expression (increased group) and 15 had normal and low tRF-LeuCAG expression (normal and decreased group); the 3-year overall survival (OS) in the increased group was significantly shorter than that in the normal and decreased groups, and the difference was statistically significant (HR=2.968; 95%CI, 1.669 to 5.277; P < 0.05). Transwell migration experiment showed that overexpression of tRF-LeuCAG promoted the migration of lung cancer cells, while decreased expression of tRF-LeuCAG inhibited the migration of lung cancer cells (P < 0.05).
The tRF-LeuCAG may be a new oncogene, which can promote the differentiation and metastasis of lung cancer cells, and provide a targeted experimental basis for tRF-LeuCAG in the treatment of metastatic LAC. The tRF-LeuCAG may also serve as a new biomarker for the diagnosis and survival prognosis of LAC in the future.
| [1] |
刘宗超, 李哲轩, 张阳, 等. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-14. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLZD202102001.htm
|
| [2] |
甘婉玲, 韩辰燕, 刘晓芯, 等. 肺癌患者免疫治疗所致皮肤毒性反应症状研究[J]. 实用临床医药杂志, 2021, 25(22): 21-25. doi: 10.7619/jcmp.20212148
|
| [3] |
SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30.
|
| [4] |
OBERBAUER V, SCHAEFER M R. tRNA-derived small RNAs: biogenesis, modification, function and potential impact on human disease development[J]. Genes, 2018, 9(12): 607.
|
| [5] |
CAO J, COWAN D B, WANG D Z. tRNA-derived small RNAs and their potential roles in cardiac hypertrophy[J]. Front Pharmacol, 2020, 11: 572941.
|
| [6] |
CHEN Z J, QI M J, SHEN B, et al. Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs[J]. Nucleic Acids Res, 2019, 47(5): 2533-2545.
|
| [7] |
SHAO Y, SUN Q L, LIU X M, et al. tRF-Leu-CAG promotes cell proliferation and cell cycle in non-small cell lung cancer[J]. Chem Biol Drug Des, 2017, 90(5): 730-738.
|
| [8] |
陈志, 王玉红, 朱卫东, 等. 联合检测7种自身抗体在非小细胞肺癌中的诊断价值[J]. 临床与实验病理学杂志, 2021, 37(2): 182-185, 191. https://www.cnki.com.cn/Article/CJFDTOTAL-LSBL202102017.htm
|
| [9] |
张翠翠, 秦婷婷, 孟昭婷, 等. 肺癌相关异常脂代谢的研究进展[J]. 中国癌症杂志, 2021, 31(1): 76-80. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ202101013.htm
|
| [10] |
郭虹, 韩微, 马怡君, 等. 非小细胞肺癌中高表达piR-1366的临床病理意义及对肿瘤转移的影响[J]. 实用医学杂志, 2021, 37(21): 2739-2742, 2747. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ202121007.htm
|
| [11] |
ZHU L W, GE J X, LI T W, et al. tRNA-derived fragments and tRNA halves: the new players in cancers[J]. Cancer Lett, 2019, 452: 31-37.
|
| [12] |
QIN C, XU P P, ZHANG X, et al. Pathological significance of tRNA-derived small RNAs in neurological disorders[J]. Neural Regen Res, 2020, 15(2): 212-221.
|
| [13] |
PANDEY K K, MADHRY D, RAVI KUMAR Y S, et al. Regulatory roles of tRNA-derived RNA fragments in human pathophysiology[J]. Mol Ther Nucleic Acids, 2021, 26: 161-173.
|
| [14] |
WANG J, LIU X Y, CUI W F, et al. Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma[J]. Cancer Cell Int, 2022, 22(1): 59.
|
| [15] |
HUANG L T, CUI M, SILVA M, et al. Expression profiles of tRNA-derived fragments and their potential roles in lung adenocarcinoma[J]. Ann Transl Med, 2022, 10(4): 196.
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: